| P50 | author | John Kjekshus | Q6243255 |
| P2093 | author name string | Stephen S Gottlieb | |
| | Leeor M Jaffe | |
| P2860 | cites work | Early signs of atherosclerosis in obstructive sleep apnea | Q48551584 |
| | Day-night pattern of sudden death in obstructive sleep apnea | Q48558148 |
| | Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study | Q48594462 |
| | Relationship among the severity of sleep apnea syndrome, cardiac arrhythmias, and autonomic imbalance | Q48630934 |
| | Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure | Q48634373 |
| | Central sleep apnea in left ventricular dysfunction: prevalence and implications for arrhythmic risk. | Q48636512 |
| | Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea | Q48640268 |
| | Severe obstructive sleep apnea is associated with left ventricular diastolic dysfunction | Q48670679 |
| | Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial | Q48672164 |
| | Sleep-disordered breathing and coronary artery disease: long-term prognosis | Q48677504 |
| | Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure | Q48684878 |
| | Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study | Q48704784 |
| | Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome | Q48705061 |
| | Platelet function in patients with obstructive sleep apnoea syndrome | Q48708646 |
| | Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: effects of nasal continuous positive airway pressure therapy | Q48713863 |
| | Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure | Q48732943 |
| | Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure | Q48741847 |
| | A mechanism of central sleep apnea in patients with heart failure | Q48743209 |
| | Influence of pulmonary capillary wedge pressure on central apnea in heart failure | Q48768829 |
| | Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. | Q48770394 |
| | Sleep apnoea and nocturnal angina. | Q48821990 |
| | Pulmonary hypertension and hypoxemia in obstructive sleep apnea syndrome | Q48851176 |
| | Treatment of obstructive sleep apnea. A preliminary report comparing nasal CPAP to nasal oxygen in patients with mild OSA. | Q48922208 |
| | The effect of oxygen on respiration and sleep in patients with congestive heart failure | Q48934360 |
| | Pulmonary hypertension, hypoxemia, and hypercapnia in obstructive sleep apnea patients | Q48937004 |
| | Daytime pulmonary hypertension in patients with obstructive sleep apnea syndrome | Q48955167 |
| | Didgeridoo playing as alternative treatment for obstructive sleep apnoea syndrome: randomised controlled trial | Q24537402 |
| | High prevalence of unrecognized sleep apnoea in drug-resistant hypertension | Q28207857 |
| | Hypoxia-inducible factor 1 mediates increased expression of NADPH oxidase-2 in response to intermittent hypoxia | Q28582257 |
| | The occurrence of sleep-disordered breathing among middle-aged adults | Q29547889 |
| | HIF-1alpha is essential for myeloid cell-mediated inflammation | Q29617581 |
| | Prospective study of the association between sleep-disordered breathing and hypertension | Q29620492 |
| | Hypoxia, not the frequency of sleep apnea, induces acute hemodynamic stress in patients with chronic heart failure | Q30434409 |
| | Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model | Q30500690 |
| | Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials | Q30954736 |
| | Sleep-disordered breathing and mortality: a prospective cohort study | Q33494520 |
| | Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes | Q33695887 |
| | Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. | Q33855764 |
| | Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes | Q33957444 |
| | Epidemiology of obstructive sleep apnea: a population health perspective | Q34126856 |
| | Sleep apnea and heart failure: Part II: central sleep apnea | Q34189061 |
| | Utility of nocturnal home oximetry for case finding in patients with suspected sleep apnea hypopnea syndrome | Q34353370 |
| | Sleep quality and blood pressure dipping in obstructive sleep apnea | Q34391956 |
| | Sleep apnea predicts distinct alterations in glucose homeostasis and biomarkers in obese adults with normal and impaired glucose metabolism | Q34408165 |
| | Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study | Q34507238 |
| | Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study | Q34508280 |
| | Resistant hypertension and obstructive sleep apnea: the sparring partners | Q34512680 |
| | Adaptive servoventilation improves cardiac function and respiratory stability | Q34551178 |
| | Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation | Q34574714 |
| | Diagnosis and initial management of obstructive sleep apnea without polysomnography: a randomized validation study | Q34574888 |
| | Obstructive sleep apnoea | Q34754606 |
| | Pulmonary arterial hypertension in patients with sleep apnoea syndrome | Q35533481 |
| | Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea. | Q35537962 |
| | Home diagnosis of sleep apnea: a systematic review of the literature. An evidence review cosponsored by the American Academy of Sleep Medicine, the American College of Chest Physicians, and the American Thoracic Society | Q35557849 |
| | Chronic intermittent hypoxia induces atherosclerosis | Q36330538 |
| | Effects of captopril and oxygen on sleep apnoea in patients with mild to moderate congestive cardiac failure | Q36817015 |
| | Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea | Q36840423 |
| | HIF-1-dependent respiratory, cardiovascular, and redox responses to chronic intermittent hypoxia | Q36879203 |
| | Obstructive sleep apnea, cardiovascular disease, and pulmonary hypertension | Q37077161 |
| | Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study | Q37144291 |
| | Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis | Q37421663 |
| | Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation | Q37465886 |
| | Hypoxia and inflammation | Q37842498 |
| | Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation | Q37870246 |
| | The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care | Q37878093 |
| | Intermittent hypoxia induces hyperlipidemia in lean mice. | Q38321740 |
| | The effect of continuous positive airway pressure on glucose control in diabetic patients with severe obstructive sleep apnea. | Q39735999 |
| | The cardiovascular effects of obstructive sleep apnoeas: analysis of pathogenic mechanisms. | Q40657850 |
| | Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study | Q40699336 |
| | Obstructive sleep apnea manifesting as suspected angina: report of three cases | Q40727958 |
| | Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure | Q40848691 |
| | Pulmonary hypertension in the obstructive sleep apnoea syndrome: prevalence, causes and therapeutic consequences | Q41050642 |
| | Adverse consequences of high sympathetic nervous activity in the failing human heart | Q41673274 |
| | Relationship of arousals from sleep to sympathetic nervous system activity and BP in obstructive sleep apnea | Q41691270 |
| | Safety and efficacy of pulmonary vein antral isolation in patients with obstructive sleep apnea: the impact of continuous positive airway pressure | Q42944902 |
| | Impairment of vascular endothelial function and left ventricular filling : association with the severity of apnea-induced hypoxemia during sleep | Q43570681 |
| | Obstructive sleep apnea is independently associated with insulin resistance. | Q43903080 |
| | Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. | Q43903083 |
| | Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. | Q44064935 |
| | Left ventricular systolic dysfunction in patients with obstructive sleep apnea syndrome | Q44178011 |
| | Clinical relevance of short-term day-time breathing disorders in chronic heart failure patients. | Q44180058 |
| | Longitudinal study of moderate weight change and sleep-disordered breathing | Q44313768 |
| | Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations | Q44554087 |
| | Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure | Q44641932 |
| | Clinical impact of screening for sleep related breathing disorders in atrial fibrillation | Q44901260 |
| | The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome | Q45069241 |
| | Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure--possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine | Q45238935 |
| | Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea | Q45287871 |
| | Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure | Q45770238 |
| | C-reactive protein is associated with obstructive sleep apnea independent of visceral obesity | Q46118312 |
| | Carvedilol reduces the severity of central sleep apnea in chronic heart failure | Q46175811 |
| | Effect of flow-triggered adaptive servo-ventilation compared with continuous positive airway pressure in patients with chronic heart failure with coexisting obstructive sleep apnea and Cheyne-Stokes respiration | Q46242784 |
| | Risk factors and prognostic value of daytime Cheyne-Stokes respiration in chronic heart failure patients. | Q46437096 |
| | Serum homocysteine levels and cardiovascular morbidity in obstructive sleep apnea syndrome | Q46604467 |
| | Continuous positive airway pressure for central sleep apnea and heart failure | Q46799634 |
| | Symptoms of obstructive sleep apnea in patients with nonalcoholic fatty liver disease | Q46896389 |
| | Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study | Q46960378 |
| | Beneficial Effects of Adaptive Servo Ventilation in Patients With Chronic Heart Failure | Q48102700 |
| | Predictors of recurrence in patients undergoing cryoballoon ablation for treatment of atrial fibrillation: the independent role of sleep-disordered breathing | Q48284435 |
| | Effect of an ambulatory diagnostic and treatment programme in patients with sleep apnoea | Q48295262 |
| | Complex sleep apnoea in congestive heart failure | Q48312901 |
| | Circadian pattern of life-threatening ventricular arrhythmia in patients with sleep-disordered breathing and implantable cardioverter-defibrillators | Q48325634 |
| | Left ventricular diastolic dysfunction is linked to severity of obstructive sleep apnoea. | Q48353298 |
| | Nocturnal rostral fluid shift: a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure | Q48364777 |
| | Efficacy of continuous positive airway pressure on arrhythmias in obstructive sleep apnea patients | Q48374338 |
| | Obstructive sleep apnea in patients admitted for acute myocardial infarction. Prevalence, predictors, and effect on microvascular perfusion | Q48398603 |
| | Sleep-disordered breathing in heart failure with normal left ventricular ejection fraction | Q48399773 |
| | A high prevalence of sleep disordered breathing in men with mild symptomatic chronic heart failure due to left ventricular systolic dysfunction | Q48400593 |
| | Pulmonary capillary wedge pressure and pulmonary arterial pressure in heart failure patients with sleep-disordered breathing | Q48413142 |
| | Adaptive servo-ventilation in heart failure patients with sleep apnea: a real world study | Q48422938 |
| | Rationale and design of the Randomized Intervention with CPAP in Coronary Artery Disease and Sleep Apnoea--RICCADSA trial | Q48427970 |
| | Effects of dynamic bilevel positive airway pressure support on central sleep apnea in men with heart failure | Q48453640 |
| | Diuretics in obstructive sleep apnea with diastolic heart failure | Q48459730 |
| | A critical role for p38 map kinase in NF-kappaB signaling during intermittent hypoxia/reoxygenation | Q48476324 |
| | Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension | Q48477183 |
| | Endothelial cell apoptosis in obstructive sleep apnea: a link to endothelial dysfunction | Q48478550 |
| | Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome | Q48481426 |
| | Activation of nuclear factor kappaB in obstructive sleep apnea: a pathway leading to systemic inflammation | Q48512187 |
| | Effects of long-term nocturnal oxygen treatment in patients with severe heart failure | Q48512550 |
| | Sleep disorders in systolic heart failure: a prospective study of 100 male patients. The final report | Q48522338 |
| | Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome | Q48525924 |
| | Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea | Q48538212 |
| | Chronic liver injury during obstructive sleep apnea | Q48550777 |
| P433 | issue | 11 | |
| P304 | page(s) | 809-815 | |
| P577 | publication date | 2012-03-16 | |
| P1433 | published in | European Heart Journal | Q2286839 |
| P1476 | title | Importance and management of chronic sleep apnoea in cardiology | |
| P478 | volume | 34 | |